Sinopharm Group Co., Ltd. (SHTDY)
Sinopharm Group Market Cap : 8.625B for Feb. 23, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Sinovac Biotech Ltd. | 464.94M |
| CASI Pharmaceuticals, Inc. | 15.72M |
| Zai Lab Ltd. | 2.210B |
| WuXi Biologics (Cayman), Inc. | 21.33B |
| Viva Biotech Holdings | 724.45M |
Market Cap Related Metrics
| PS Ratio | 0.1081 |
| Price to Free Cash Flow | 34.32 |
| Price | 13.82 |
| Earnings Yield | 10.94% |
| Operating PE Ratio | 3.766 |
| Normalized PE Ratio | 8.246 |